Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Influenza
Influenza.png
Filter     Order     Display # 
Date Item Title Hits
05 Nov 2009 Daiichi Sankyo Launches New Phase 3 Trial with CS-8958 for Flu Prevention 1497
25 May 2007 Iomai Announces Interim Results From Phase 1 Study of Its Patch-Based Vaccine for Seasonal Influenza 1523
16 May 2007 Next Generation Nasal Spray Against Influenza: Clinical Phase I Study Started With FLUVACCdelNS1 961
08 May 2007 4SC AG Provides Proof of Concept for Drug Candidate SC75741 in the Treatment of Influenza A-infected Mice 943
08 May 2007 Focetria(R), the Novartis pandemic influenza vaccine, receives European Union approval 910
03 May 2007 ANX-201 Drug Combination Demonstrates Synergistic Activity Against Human and Bird Flu Viruses 887
27 Apr 2007 Optaflu(R), the Novartis cell culture-derived influenza vaccine, receives positive opinion supporting European Union regulatory approval 1162
18 Apr 2007 Completion of Phase I Trial on the Anti-influenza Drug CS-8958 1047
04 Apr 2007 CytoGenix Announces Successful Testing of synDNA(TM) Vaccine for Avian Influenza Virus 954
02 Apr 2007 CSL Biotherapies Submits BLA to Introduce Flu Vaccine to U.S. Market 967
02 Apr 2007 Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data Show 942
29 Mar 2007 Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 943
05 Mar 2007 New studies indicate GSK's pre-pandemic influenza vaccine can protect against different strains of H5N1 1080
23 Feb 2007 Focetria(R) pandemic influenza vaccine receives positive European Union regulatory agency opinion supporting approval 1051
21 Feb 2007 Pre-Clinical Study of Novavax's Seasonal Influenza Vaccine Published in Journal 'Vaccine' 1096
30 Jan 2007 BioSante Pharmaceuticals Announces Positive Bird Flu Results Using Proprietary Vaccine Adjuvant in Pre-Clinical Study 1483
29 Jan 2007 GlaxoSmithKline files its new pre-pandemic influenza vaccine in Europe 1222
25 Jan 2007 Biocryst Initiates Phase II Influenza Clinical Trial To Evaluate Peramivir 1180
15 Dec 2006 GlaxoSmithKline reaches EU regulatory milestone in its flu pandemic vaccine development programme 1287
09 Nov 2006 MedImmune Files Investigational New Drug Application for Cell Culture-Based Influenza Vaccine 1300
08 Nov 2006 Novavax's Pandemic Influenza Vaccine Candidates Trigger Robust Immune Response In Pre-Clinical Models 1245
06 Nov 2006 Generex Biotechnology to Begin the First Human Clinical Trial of Avian Influenza Vaccine 1252
20 Oct 2006 Single Injection of Vical's Avian Flu DNA Vaccine Provides 100% Protection in Ferrets 1358
18 Oct 2006 MediVas, LLC Announces Positive Preclinical Ferret Data Against H5N1 1362
04 Oct 2006 Baxter Announces Safety and Immunogenicity Results from Phase I/II Clinical Trial of Cell-Based Candidate H5N1 Pandemic Vaccine 1460
26 Sep 2006 Sanofi pasteur Cell Culture-Based Seasonal Influenza Vaccine Enters First Clinical Trial 1602
28 Aug 2006 Preliminary Result of Phase I Clinical Trial Shows That Sinovac's Pandemic Influenza Vaccine (H5N1) has High Safety and Immunogenicity Profile 1463
21 Aug 2006 Dynavax's Flu Vaccine Shows Immunity to Divergent and Potentially Pandemic Flu Strains in Preclinical Tests 1365
31 Jul 2006 Novavax Succeeds in Making Vaccine to Protect Against New Mutation of Avian Influenza 1358
31 Jul 2006 MedImmune Submits Refrigerator-Stable Formulation of FluMist® to FDA for Approval in Younger Children 1450
 
<< Start < Prev 1 2 3 Next > End >>
Results 1 - 30 of 83

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Tau and Amyloid Beta Targeted Therapy of Alzheimer’s Disease

Order Now

Recommended Report

R&D Drug Pipeline Database
Order Now

Subscribe La Merie Biologics